Use of human recombinant antibodies to the marker of angiogenesis ed-b in cancer therapy.
Borsi
L
L
Laboratory of Cell Biology, National Cancer Research Institute, Genoa, Italy.
Carnemolla
B
B
Neri
D
D
Zardi
L
L
D000818:Animals; D000906:Antibodies / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000276:immunology*; D006801:Humans; D018664:Interleukin-12 / Q000627:therapeutic use; D019409:Interleukin-15 / Q000627:therapeutic use; D007376:Interleukin-2 / Q000627:therapeutic use; D009369:Neoplasms / Q000098:blood supply / Q000188:drug therapy* / Q000276:immunology; D009389:Neovascularization, Pathologic / Q000276:immunology*; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use*; D012269:Ribosomal Proteins / Q000627:therapeutic use*; D014409:Tumor Necrosis Factor-alpha / Q000627:therapeutic use
D000906:Antibodies; D014408:Biomarkers, Tumor; D019409:Interleukin-15; D007376:Interleukin-2; C489092:RPL19 protein, human; D011993:Recombinant Fusion Proteins; D012269:Ribosomal Proteins; D014409:Tumor Necrosis Factor-alpha; D018664:Interleukin-12